Swallowing in Parkinson patients versus healthy controls: reliability of measurements in videofluoroscopy by Baijens, Laura W.J. et al.
Hindawi Publishing Corporation
Gastroenterology Research and Practice
Volume 2011, Article ID 380682, 9 pages
doi:10.1155/2011/380682
Research Article
Swallowing in Parkinson Patients versus Healthy Controls:
Reliability of Measurements in Videofluoroscopy
Laura W. J. Baijens,1 Rene´e Speyer,1, 2 Vale´ria Lima Passos,3 Walmari Pilz,1
Nel Roodenburg,4 and Pere Clave5
1Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, P.O. Box 5800,
6202 AZ Maastricht, The Netherlands
2Department of Speech and Language Pathology, HAN University of Applied Sciences, 6525 EN Nijmegen, The Netherlands
3Department of Methodology and Statistics, Maastricht University, 6229 HA Maastricht, The Netherlands
4Department of Neurology, Maastricht University Medical Center, 6202 AZ Maastricht, The Netherlands
5Departamento de Cirug´ıa, Hospital de Mataro´y CIBEREHD, Instituto de Salud Carlos III, Mataro´, Spain
Correspondence should be addressed to Laura W. J. Baijens, laura.baijens@mumc.nl
Received 14 February 2011; Accepted 9 July 2011
Academic Editor: Roberto O. Dantas
Copyright © 2011 Laura W. J. Baijens et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Objective. To determine and describe the pathophysiological aspects of oropharyngeal swallowing in patients with Parkinson’s
disease more accurately, a pilot study of qualitative as well as quantitative parameters of swallowing was performed using vide-
ofluoroscopy (VFS).Methods. Ten patients with a diagnosis of idiopathic Parkinson’s disease having dysphagic complaints and ten
healthy age- and gender-matched control subjects underwent a standardized videofluoroscopic swallowing protocol. Information
on the swallowing function was derived from temporal, spatial, and descriptive visuoperceptual parameters. Intra- and interrater
reliability was calculated. Results. No significant differences were found between Parkinson patients and healthy control subjects
for the majority of the reliable variables. Conclusions. It was concluded that swallowing function seemed to be preserved in the
early stages of Parkinson’s disease. Furthermore, the reliability of many quantitative as well as qualitative swallowing parameters
proved insufficient, raising questions about the interpretation of study outcomes in videofluoroscopy.
1. Introduction
Dysphagia is a common symptom of Parkinson’s disease [1].
In 75–100% of patients with Parkinson’s disease, swallowing
abnormalities have been observed during videofluoroscopic
examination (VFS) [2]. Severe dysphagia can result in mal-
nutrition, dehydration, aspiration pneumonia, and sudden
death [3]. Tracheal aspiration is not an uncommon phenom-
enon in Parkinson patients [2, 4–6]. A substantial number of
them do not have subjective complaints of dysphagia, despite
the presence of abnormalities observed in the swallowing
act, including silent aspiration during VFS examination [2,
6]. The quality of life decreases as the dysphagia progres-
sively affects oral feeding [7, 8]. Previous studies describe
oral and pharyngeal phase abnormalities during VFS exam-
ination using visuoperceptual parameters, such as piecemeal
deglutition, pumping tongue motion, or postswallow vallec-
ular pooling, while others use timed parameters, for example,
oropharyngeal transit time, duration of the upper esophageal
sphincter opening, or total swallow duration [5, 9, 10]. There
is hardly any literature on the pathophysiology of swallowing
in patients with Parkinson’s disease using spatial or timed
parameters in VFS recordings [6].
The purpose of this study is twofold: to determine the
reliability of timed as well as spatial parameters in videoflu-
oroscopy of swallowing necessary to interpret the study out-
come and to determine the differences in swallowing func-
tion between patients with Parkinson’s disease and healthy
control subjects, matched for age and gender. Qualita-
tive assessment of swallows was based on visuoperceptual
evaluation of videofluoroscopic signs by an expert panel,
whereas quantitative assessment was obtained by means of
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Table 1: Subject characteristics.
Number of
matched pair
of subjects
Sex
(female/male)
Patients with Parkinson’s disease Healthy controls
Hoehn and Yahr
scalea (H&Y)
Duration of Parkinson’s
disease (years)
Functional oral
intake scaleb (FOIS)
Age
(years)
Age (years)
1 M I 5 7 70 68
2 F II 7 7 64 63
3 M II 7 7 50 46
4 M III 6 7 80 81
5 F II >5 7 73 74
6 M III 5 7 57 53
7 F III 7 7 62 60
8 M II 7 5 70 67
9 M III 16 7 70 70
10 M I >5 7 66 68
a
(H&Y): the range of scores is one to five, indicating, respectively, unilateral involvement usually with minimal or no functional disability, and confinement
to bed or wheelchair unless aided [12].
b(FOIS): the range of scores is one to seven, indicating nothing by mouth to total oral diet with no restrictions [13].
a specialized computer software application that allowed
capturing and digitizing frames in videofluoroscopic record-
ings. Using the manual input of anatomical references deter-
mined by an expert panel, parameters could be measured.
2. Methods
2.1. Subject Populations. Patients with idiopathic Parkinson’s
disease (diagnosed by a neurologist) having subjective clin-
ical complaints of dysphagia were recruited from several
neurological departments in the Netherlands. All patients
reported dysphagic complaints ranging from mild to severe,
for example, these included slow eating, oral or pharyngeal
passage disorder, coughing while drinking, and a diminished
quality of life as a direct consequence of dysphagia. None of
them suffered from any neurological disease except Parkin-
son’s. All patients were able to perform a swallow. Other
exclusion criteria were deep brain stimulation (DBS), a Mini
Mental State Examination (MMSE) score below 23, severe
dyskinesia of head and neck (resulting in problems with VFS
recording), mental depression, head and neck cancer, severe
cardiopulmological disease, speech therapy during the past
six months, or surgery of the swallowing mechanism or the
central nervous system [11]. All patients showed a stable
disease period at the time of inclusion and had been on the
same antiparkinsonian medication regimen for more than
two months. The clinical severity of the disease was scored
using the Hoehn and Yahr (H&Y) staging scale (Table 1)
[12]. Healthy control subjects from the department of otor-
hinolaryngology, head and neck surgery of the university
medical center were matched by age and gender. The age
difference between the patient and his or hermatched control
subject was less than four years. The control subjects did
not have complaints of swallowing, mental depression, any
neurological disease, or head and neck cancer. Nor had they
undergone surgery of the swallowing mechanism or the cen-
tral nervous system. Written informed consent was obtained
from all patients and healthy control subjects. This study
protocol was approved by the medical ethical committee of
the university medical center.
2.2. Swallowing Assessment. All patients underwent a de-
tailed clinical examination by an experienced laryngologist
and a speech and language pathologist. Before the VFS ex-
amination the presence and severity of dysphagia were as-
sessed using the Functional Oral Intake Scale (FOIS) and
a fiberoptic endoscopic evaluation of swallowing (FEES)
[13, 14]. Following these examinations, all subjects under-
went a standardized videofluoroscopic swallowing protocol
of three trials of thin liquid (forming part of a more elab-
orate experiment to be published in a subsequent report).
Each trial contained 10 cc of low-density barium (40%
w/v barium boluses) delivered orally by a syringe. The
subjects had to swallow the bolus after it had been accu-
rately delivered by syringe in the oral cavity resulting in
a motor challenge without any preparatory cue. The VFS was
performed in lateral position. Subjects were seated upright
wearing their dental prosthesis (if present). The lips, oral
cavity, cervical spine, and proximal cervical esophagus were
included in the recording. A coin of five eurocents was
fixed on the retroauricular skin as a reference distance to
correct for magnification. Videofluoroscopic images were
obtained with a Philips Diagnost 97 system (Philips Medical
Systems, Eindhoven, The Netherlands) and recorded on
cassette at 25 frames per second using a mini-DV camera-
recorder Panasonic AG-DVC30 (Matsushita Electric Indus-
trial Co., Osaka, Japan). If mild aspiration during a trial
was observed, a subsequent trial was administered, but in
case of severe aspiration the examination was ended. All
examinations were performed within 90–120 minutes after
the intake of antiparkinsonian medication, thus, during the
“on” motor phase [15]. The VFS was performed by an
independent experienced speech therapist together with the
radiologist.
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2.3. Measurements. Swallows were analyzed using a specific
software application (Image & Physiology SL, Barcelona,
Spain) to capture, digitize, andmeasure the videofluoroscop-
ic swallowing sequences [16]. All variables are defined in
Table 2.
Quantitative measurements were determined for each
swallow by two experienced raters with extensive training
in the analysis of VFS studies of normal and disordered
swallowing. Kahrilas et al. used more physiologic references
to calculate timed variables in contrast with fixed anatomical
landmarks, like the point where the mandible crosses
the tongue base [17]. In this study, timed variables for
biomechanical analysis of swallowing were defined according
to Kahrilas et al.: moment of opening and closing of the
glossopalatal junction (GPJ); moment of opening and clos-
ing of velopharyngeal junction (VPJ); moment of opening
and closing of laryngeal vestibule (LV); moment of opening
and closing of upper esophageal sphincter (UES). The frame
exhibiting penetration or aspiration wasmarked by the raters
as timed event as well. Penetration was defined as passage of
bolus into the laryngeal vestibule. Aspiration was defined as
passage of bolus below the level of the vocal folds.
Movement patterns of the hyoid bone as described by
Logemann et al. were used as spatial variables to analyze
the swallowing function [18]. For each swallow three points
were marked in each video frame: the anterior/superior
corner of the hyoid bone and the anterior/inferior corner
of the third and fifth cervical vertebral bodies. The y-axis
was defined by the anterior/inferior corner of the third and
fifth cervical vertebral bodies. The x-axis crosses the y-axis
at the anterior/inferior corner of the third vertebral body. By
marking these reference points in each frame, movements of
the subject in any plane were corrected (Figure 1). Software
analyzed the extent of movement of the hyoid bone in the x-y
coordinate system over time.
The following visuoperceptual parameters to evaluate
videofluoroscopic signs were scored: preswallow anterior and
preswallow posterior spill; lingual pumping; swallow hesi-
tancy; piecemeal deglutition; delayed initiation of the pha-
ryngeal reflex; postswallow oral residue; postswallow vallec-
ular pooling; postswallow pyriform sinus pooling [7, 19].
Furthermore, the penetration aspiration scale according to
Rosenbek et al. was scored for all VFS studies [20]. This
eight-point scale (1–8) contains lower scores referring to nor-
mal functioning whereas higher scores refer to more severe
disability.
Following consensus training, two experts assessed all
quantitative and qualitative variables independently at vary-
ing speed, ranging from normal to slow motion to frame-
by-frame viewing. The raters were blinded to the diagnosis
(Parkinson versus healthy subjects) and swallow trials were
scored in randomized order. The consensus training in
visuoperceptual evaluation was accompanied by a manual
including strict, well-defined guidelines to rate these ordinal
variables. The exact interpretation per level of each of the
three or five point scales was trained during five separate
sessions with intervals of one week. During these intervals
the expert raters had to accomplish test trials separately that
were discussed the next session.
Ant2
Ant3
Arytenoid
SGL
Ant UES
Post UES
Hyoid
Figure 1: Single frame of the videofluoroscopic recording showing
the landmarks used for spatial measurements. Extent of movement
of the hyoid bone in the x-y coordinate system. The square encloses
four electrodes in position during status “electrical current off,” the
oval includes the marked hyoid bone, and the circle indicates the
x-y coordinate system.
To obtain the intrarater reliability each rater performed
repeated measurements of all temporal, spatial, and visuop-
erceptual variables in all swallows within a period of two
weeks.
2.4. Statistical Analysis. Statistical analysis was conducted
stepwise. First, Intraclass Correlation Coefficients (ICC) and
Cronbach’s alphas (>0.65) were computed for all quantitative
parameters to determine the reliability and the degree of
intra- and interrater (absolute) agreement. For all ordinal
parameters Cohen’s Kappa index of agreement was used.
Second, for each reliable temporal, spatial, and visuopercep-
tual variable, group comparisons were performed over the
averaged data of the expert raters. Differences between the
Parkinson and the healthy control populations were tested
for significance by means of the Mann-Whitney U test (tem-
poral and spatial, continuous variables) or the Chi-Square
test (visuoperceptual, ordinal variables). All statistical anal-
yses were performed using SPSS version 16.0 for Windows
(SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Subject Populations. Ten mentally competent dysphagic
patients (3 women, 7 men) with a diagnosis of idiopathic
Parkinson’s disease were included. The H&Y staging scale
ranged from mild to moderate (median II). Table 1 shows
the subject characteristics of all participants. The mean age
of the patients and the controls was, respectively, 66 and 65
years. The duration of their Parkinson’s disease ranged from
5 to 13 years. The median of the FOIS score in the Parkinson
patients was 7. The range of scores of the FOIS is one to
seven, indicating nothing by mouth to total oral diet with no
restrictions. Subjective complaints of the patients included,
4 Gastroenterology Research and Practice
T
a
bl
e
2:
M
ea
su
re
m
en
ts
in
vi
de
ofl
u
or
os
co
py
.
M
et
h
od
of
m
ea
su
re
m
en
t
Pa
ra
m
et
er
s
N
am
e
D
efi
n
it
io
n
R
at
in
g
sc
al
e
or
u
n
it
s
Te
m
po
ra
lp
ar
am
et
er
s
G
P
Jo
(G
lo
ss
op
al
at
al
ju
n
ct
io
n
op
en
in
g)
M
om
en
to
fs
ep
ar
at
io
n
of
th
e
to
n
gu
e
an
d
so
ft
pa
la
te
.
Se
co
n
ds
G
P
Jc
(G
lo
ss
op
al
at
al
ju
n
ct
io
n
cl
os
u
re
)
M
om
en
to
fc
on
ta
ct
of
th
e
to
n
gu
e
an
d
pa
la
te
af
te
r
bo
lu
s
pr
op
u
ls
io
n
.
G
P
Jd
(G
lo
ss
op
al
at
al
ju
n
ct
io
n
du
ra
ti
on
)
Δ
T
be
tw
ee
n
G
P
Jo
an
d
G
P
Jc
.
V
P
Jc
(V
el
op
h
ar
yn
ge
al
ju
n
ct
io
n
cl
os
u
re
)
M
om
en
to
ffi
rs
t
co
n
ta
ct
of
th
e
so
ft
pa
la
te
ag
ai
n
st
th
e
po
st
er
io
r
ph
ar
yn
ge
al
w
al
l.
V
P
Jo
(V
el
op
h
ar
yn
ge
al
ju
n
ct
io
n
op
en
in
g)
M
om
en
to
fs
ep
ar
at
io
n
of
th
e
so
ft
pa
la
te
an
d
th
e
po
st
er
io
r
ph
ar
yn
ge
al
w
al
lw
it
h
re
en
tr
y
of
ai
r
in
th
e
re
tr
ol
in
gu
al
sp
ac
e
fr
om
th
e
n
as
op
h
ar
yn
x.
V
P
Jd
(V
el
op
h
ar
yn
ge
al
ju
n
ct
io
n
du
ra
ti
on
)
Δ
T
be
tw
ee
n
V
P
Jc
an
d
V
P
Jo
LV
c
(L
ar
yn
ge
al
ve
st
ib
u
le
cl
os
u
re
)
M
om
en
tw
h
en
la
ry
n
ge
al
el
ev
at
io
n
re
su
lt
s
in
m
ak
in
g
co
n
ta
ct
be
tw
ee
n
th
e
ar
yt
en
oi
d
ca
rt
ila
ge
s
an
d
th
e
u
n
de
rs
id
e
of
th
e
ep
ig
lo
tt
is
.
LV
o
(L
ar
yn
ge
al
ve
st
ib
u
le
op
en
in
g)
M
om
en
to
fs
ep
ar
at
io
n
of
th
e
ar
yt
en
oi
d
ca
rt
ila
ge
s
an
d
th
e
u
n
de
rs
id
e
of
th
e
ep
ig
lo
tt
is
w
it
h
re
en
tr
y
of
ai
r
in
th
e
la
ry
n
ge
al
ve
st
ib
u
le
.
LV
d
(L
ar
yn
ge
al
ve
st
ib
u
le
du
ra
ti
on
)
Δ
T
be
tw
ee
n
LV
c
an
d
LV
o
U
E
So
(U
pp
er
es
op
h
ag
ea
ls
ph
in
ct
er
op
en
in
g)
M
om
en
to
fo
pe
n
in
g
of
th
e
es
op
h
ag
u
s
w
it
h
en
tr
y
of
ei
th
er
ai
r
or
ba
ri
u
m
.
U
E
Sc
(U
pp
er
es
op
h
ag
ea
ls
ph
in
ct
er
cl
os
u
re
)
M
om
en
to
fc
lo
su
re
of
th
e
es
op
h
ag
u
s
af
te
r
bo
lu
s
tr
an
sp
or
t.
U
E
Sd
(U
pp
er
es
op
h
ag
ea
ls
ph
in
ct
er
du
ra
ti
on
)
Δ
T
be
tw
ee
n
U
E
So
an
d
U
E
Sc
G
P
Jo
-L
V
c
Δ
T
be
tw
ee
n
G
P
Jo
an
d
LV
c
G
P
Jo
-U
E
So
Δ
T
be
tw
ee
n
G
P
Jo
an
d
U
E
So
G
P
Jo
-U
E
Sc
Δ
T
be
tw
ee
n
G
P
Jo
an
d
U
E
Sc
A
sp
ir
at
io
n
-p
en
et
ra
ti
on
M
om
en
to
fa
sp
ir
at
io
n
or
pe
n
et
ra
ti
on
Sp
at
ia
la
n
d
te
m
po
ra
l
pa
ra
m
et
er
s
(h
yo
id
m
ot
io
n
)
H
or
iz
on
ta
lh
yo
id
m
ot
io
n
M
ax
im
u
m
h
or
iz
on
ta
l(
an
te
ri
or
)
m
ot
io
n
du
ri
n
g
sw
al
lo
w
in
g
ac
t.
M
ill
im
et
er
s
V
er
ti
ca
lh
yo
id
m
ot
io
n
M
ax
im
u
m
ve
rt
ic
al
m
ot
io
n
du
ri
n
g
sw
al
lo
w
in
g
ac
t.
M
ill
im
et
er
s
D
u
ra
ti
on
ve
rt
ic
al
hy
oi
d
m
ot
io
n
D
u
ra
ti
on
be
tw
ee
n
in
it
ia
ti
on
of
sw
al
lo
w
an
d
m
om
en
to
fm
ax
im
u
m
ve
rt
ic
al
m
ot
io
n
.
Se
co
n
ds
D
u
ra
ti
on
h
or
iz
on
ta
lh
yo
id
m
ot
io
n
D
u
ra
ti
on
be
tw
ee
n
in
it
ia
ti
on
of
sw
al
lo
w
an
d
m
om
en
to
fm
ax
im
u
m
h
or
iz
on
ta
l
(a
n
te
ri
or
)
m
ot
io
n
.
Se
co
n
ds
V
is
u
op
er
ce
pt
u
al
pa
ra
m
et
er
sa
P
re
sw
al
lo
w
an
te
ri
or
sp
ill
P
re
sw
al
lo
w
lo
ss
of
bo
lu
s
fr
om
th
e
lip
s
Fi
ve
-p
oi
n
t
sc
al
e
(0
–4
)
P
re
sw
al
lo
w
po
st
er
io
r
sp
ill
P
re
sw
al
lo
w
lo
ss
of
bo
lu
s
in
to
th
e
ph
ar
yn
x
Fi
ve
-p
oi
n
t
sc
al
e
(0
–4
)
L
in
gu
al
pu
m
pi
n
g
P
re
sw
al
lo
w
in
vo
lu
n
ta
ry
re
pe
ti
ti
ve
to
n
gu
e
m
ov
em
en
ts
Fi
ve
-p
oi
n
t
sc
al
e
(0
–4
)
Sw
al
lo
w
h
es
it
an
cy
D
el
ay
ed
on
se
t
or
al
tr
an
sp
or
t
T
h
re
e-
po
in
t
sc
al
e
(0
–2
)
P
ie
ce
m
ea
ld
eg
lu
ti
ti
on
Se
qu
en
ti
al
sw
al
lo
w
in
g
on
th
e
sa
m
e
bo
lu
s
Fi
ve
-p
oi
n
t
sc
al
e
(0
–4
)
D
el
ay
ed
in
it
ia
ti
on
ph
ar
yn
ge
al
re
fl
ex
D
el
ay
ed
on
se
t
ph
ar
yn
ge
al
tr
ig
ge
ri
n
g
T
h
re
e-
po
in
t
sc
al
e
(0
–2
)
Po
st
sw
al
lo
w
or
al
re
si
du
e
Po
st
sw
al
lo
w
po
ol
in
g
in
th
e
or
al
ca
vi
ty
Fi
ve
-p
oi
n
t
sc
al
e
(0
–4
)
Po
st
sw
al
lo
w
va
lle
cu
la
r
po
ol
in
g
Po
st
sw
al
lo
w
po
ol
in
g
in
th
e
va
lle
cu
la
e
T
h
re
e-
po
in
t
sc
al
e
(0
–2
)
Po
st
sw
al
lo
w
py
ri
fo
rm
si
n
u
s
po
ol
in
g
Po
st
sw
al
lo
w
po
ol
in
g
in
th
e
py
ri
fo
rm
si
n
u
se
s
T
h
re
e-
po
in
t
sc
al
e
(0
–2
)
Pe
n
et
ra
ti
on
as
pi
ra
ti
on
sc
al
e
(P
A
S)
[2
0]
Pe
n
et
ra
ti
on
an
d/
or
as
pi
ra
ti
on
E
ig
h
t-
po
in
t
sc
al
e
(1
–8
)
a
Lo
w
er
sc
or
es
re
fe
r
to
n
or
m
al
fu
n
ct
io
n
in
g
w
he
re
as
hi
gh
er
sc
or
es
re
fe
r
to
m
or
e
se
ve
re
di
sa
bi
lit
y.
Gastroenterology Research and Practice 5
for example, extremely slow eating, oral or pharyngeal pas-
sage disorder, food stuck in the throat, coughing while drink-
ing, coughing during meals, and a diminished quality of life
as a direct consequence of dysphagia.
3.2. Reliability of Quantitative and Qualitative Evaluation of
Videofluoroscopy. In Tables 3(a), 3(b), and 3(c) the intrarater
and interrater reliability of the applied variables is presented.
Visuoperceptual variables like preswallow anterior and
preswallow posterior spill, swallow hesitancy, and postswal-
low oral residue mainly scored zero points, meaning normal
without any disturbances. It was decided to exclude these
variables because of insufficient relevance to this Parkinson
patient group. In contrast to the interrater reliability, it
proved that the intrarater reliability was sufficient for some
variables: delayed initiation pharyngeal reflex; UESd; GPJo-
UESc; maximum horizontal (anterior) hyoid motion, for
example. When the intrarater reliability proved to be rather
low (ICC < 0.60), however, the interrater reliability was not
computed; this was the case for GPJc, GPJd, UESo, GPJo-
UESo, and penetration-aspiration scale, among others.
3.3. Group Differences. Tables 4(a), 4(b), and 4(c) contain
descriptive statistics of the reliable temporal, spatial, and
visuoperceptual data (ICCs ≥ 0.60, Cohen’s Kappa ≥ 0.60).
To detect differences in swallowing physiology, data were
tested for significant differences between Parkinson patients
and the healthy control subjects. Using the Mann-Whitney
U test, no significant differences were found regarding the
spatial variables. The Chi-Square test did not reveal sig-
nificant group differences for the visuoperceptual variables.
The temporal variable VPJc showed a significant difference
between the two groups. Patients with Parkinson’s disease
showed a significantly delayed velopharyngeal junction clo-
sure compared to healthy controls.
4. Discussion
Before interpreting the present study outcome, the intrarater
and interrater reliability was determined. Despite the thor-
ough consensus training using well-defined guidelines as
well as the strict methodological protocol for repeated mea-
surements by the expert raters to calculate the intra- and
interrater reliability in the present study poor reliability was
observed for several parameters. Diverse situations may have
contributed to this finding. First, despite their high expertise,
the raters may have lacked consensus on a definition of, for
example, delayed initiation of the pharyngeal reflex or max-
imum horizontal (anterior) hyoid motion. Second, patients
were found to be rather homogeneous with respect to several
of the variables being measured; that is, some of them, such
as preswallow anterior spill and preswallow posterior spill,
always scored zero. Finally, it cannot be excluded that the lack
of internal consistency may have resulted from the nature
of the measurement scales and/or instruments; for instance,
visuoperceptual variables were scored on three or five point
scales. As worldwide no strict guidelines exist, some scope
for subjectivity was left to the rater in the discrimination of
these ordinal variables. Consequently, these variables were
less reliable compared to the temporal or spatial variables
that were defined frame by frame using specific software [16].
This software-guided measurement technique, however, is
not without its problems either. The fact that a few quantita-
tive variables, for instance GPJo or UESo, were only present
or visible in a single frame because of the high speed of
movement during the swallowing act may have increased the
measurement error and/or the rater’s inaccuracy. Further-
more, themethod proved to be rather labor intensive. Finally,
fifteen variables could be used for further comparison be-
tween Parkinson patients and healthy control subjects.
Despite the presence of a disturbed swallow physiology
in Parkinson patients, few significant differences were found
between the two pilot groups. Velopharyngeal junction clo-
sure (VPJc) was different, being significantly delayed in
the Parkinson group. The remaining temporal, spatial, or
visuoperceptual variables did not show significant differences
or tendencies between the groups. The lack of significant
group differences can be the result of the nature and sensi-
tivity of the assessment tool (VFS). As described in the study
of Ertekin et al. conflicting results obtained from radiological
and manometric studies in Parkinson patients were found
[21]. Also normal motility of the UES region during VFS was
observed despite the presence of manometric abnormalities
in the same region. In the present pilot study, preservation of
the swallowing function during the early stages of Parkin-
son’s disease was found using VFS despite the presence of
subjective swallowing complaints in the patients. However, if
other assessment tools, for example, manometry might have
been used, the study outcome could have been different and
abnormalities in swallowing may have been demonstrated.
Ertekin et al. also described some compensatory mechanisms
in the course of Parkinson’s disease that may explain the
benign nature of the deglutition disorder with preservation
of swallowing until the terminal stage of the disease [21].
Other explanations for the lack of significance may lie in
the advanced age of all subjects (presbyphagia), the rather
small sample size, and the moderate severity of Parkinson’s
disease in the patient population (H&Y scale) [5, 7]. For
several mainly logistic reasons (e.g., not being able to sit
upright for VFS, too weak condition for repeated transport to
the outpatient clinic for dysphagia, suffering from Parkinson
dementia), patients with severe Parkinson disease who are
often admitted to nursing homes did not find easy access to
this study. However, the population of included patients was
a realistic representation of Parkinson patients consulting a
speech therapist for dysphagic complaints. Next, the mech-
anism of pharyngeal triggering is age dependent [22]. Proba-
bly, the natural aging process in the control subjects has been
accompanied by altered swallowing function. Furthermore,
the presence of electrodes on the skin, which had been used
for another study during the same videofluoroscopic exami-
nation, may have worked as tactile cueing in the Parkinson
group, even though no electrical stimulation was given
[23]. Such cueing may have improved the swallowing per-
formance. Finally, only low-density barium boluses were
applied. The subjects had to swallow the bolus after it
had been accurately delivered by syringe in the oral cavity.
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Table 3: (a) Reliability of the temporal variables (quantitative assessment), intraclass correlation coefficients (ICC)a. (b) Reliability of the
spatial-temporal variables (hyoid motion), ICCa. (c) Reliability of the visuoperceptual variables (qualitative assessment), Cohen’s Kappa.
(a)
Temporal variable
Intrarater test-retest reliability (ICC) Interrater reliability
(ICC)Rater 1 Rater 2
GPJ opening — — —
GPJ closure 0.4 0.8 —
GPJ duration 0.4 0.8 —
VPJ closure 0.6 0.8 0.7
VPJ opening 1.0 1.0 0.7
VPJ duration 0.9 1.0 0.7
LV closure 0.9 0.9 0.9
LV opening 0.9 0.6 1.0
LV duration 1.0 0.7 0.9
UES opening 0.4 0.5 —
UES closure 0.6 0.8 0.8
UES duration 0.7 0.8 −0.1
GPJo LVc 0.9 0.9 0.9
GPJo UESo 0.4 0.9 —
GPJo UESc 0.6 0.8 −0.02
Aspiration or penetration — — —
a
Single measures ICC, Cronbach’s alpha >0.65.
(b)
Spatial-temporal variable
Intrarater test-retest reliability (ICC) Interrater reliability
(ICC)Rater 1 Rater 2
Maximum horizontal (anterior) hyoid motion. 0.9 0.6 —
Maximum vertical hyoid motion. 0.8 0.9 0.8
Duration between initiation of swallow and moment of
maximum horizontal (anterior) hyoid motion.
0.9 0.9 0.9
Duration between initiation of swallow and moment of
maximum vertical hyoid motion.
0.6 0.7 0.9
a
Single measures ICC, Cronbach’s alpha >0.65.
(c)
Visuoperceptual variable
Intrarater test-retest reliability Interrater reliability
Cohen’s Kappa Cohen’s Kappa
Rater 1 Rater 2 Rater 1-2
Preswallow anterior spill — — —
Preswallow posterior spill 1.0 1.0 —
Lingual pumping 1.0 1.0 0.6
Swallow hesitancy 1.0 — —
Piecemeal deglutition 1.0 1.0 0.9
Delayed initiation pharyngeal reflex 0.8 1.0 0.3
Postswallow oral residue 0.6 0.7 —
Postswallow vallecular pooling 0.9 0.9 0.6
Postswallow pyriform sinus pooling 0.8 1.0 0.6
Penetration aspiration [20] 1.0 — —
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Table 4: (a) Descriptive statistics of temporal data (quantitative assessment) and level of significance (P) for the comparison of differences
between Parkinson patients and the healthy control subjects (Mann-WhitneyU test asymp. sig., 2-tailed). (b) Descriptive statistics of spatial-
temporal data (hyoid motion) and level of significance (P) for the comparison of differences between Parkinson patients and the healthy
control subjects (Mann-WhitneyU test asymp. sig., 2-tailed). (c) Crosstabulation of visuoperceptual data and level of significance (P) for the
comparison of differences between Parkinson patients and the healthy control subjects (Chi-Square test asymp. sig., 2-sided). The number
of swallows per level of the three or five point scales is in parentheses.
(a)
Temporal parameters
Parkinson’s disease Healthy controls Statistical analyses
Median 25′, 75′ perc. Median 25′, 75′ perc. P value
VPJ closure 0.08 0.02, 0.12 0.03 −0.02, 0.06 0.02
VPJ opening 0.76 0.64, 1.00 0.71 0.66, 0.78 0.31
VPJ duration 0.70 0.55, 0.94 0.66 0.64, 0.74 0.78
LV closure 0.13 0.10, 0.26 0.12 0.10, 0.20 0.58
LV opening 0.91 0.72, 0.98 0.84 0.78, 0.91 0.51
LV duration 0.69 0.60, 0.80 0.66 0.60, 0.78 0.78
UES closure 0.86 0.74, 1.14 0.79 0.74, 0.86 0.13
GPJo-LV closure Δt (sec) 0.13 0.10, 0.26 0.12 0.10, 0.20 0.58
(b)
Spatial-temporal parameters
Parkinson’s disease Healthy controls Statistical analyses
Median 25′, 75′ perc. Median 25′, 75′ perc. P value
Maximum vertical hyoid motion (mm) 13.68 9.26, 20.02 14.68 13.26, 19.50 0.35
Duration between initiation of swallow and moment of
maximum anterior/horizontal hyoid motion Δt (sec)
1.64 1.01, 2.62 1.12 0.86, 2.16 0.29
Duration between initiation of swallow and moment of
maximum vertical hyoid motion Δt (sec)
1.72 1.04, 2.09 1.28 0.88, 2.04 0.48
(c)
Visuoperceptual
(ordinal) parameters
Parkinson’s disease Healthy controls P value
Lingual pumping
0 1 2 3 4 0 1 2 3 4
0.3576% 17% 7% 0% 0% 83% 17% 0% 0% 0%
(23) (5) (2) (0) (0) (25) (5) (0) (0) (0)
Piecemeal deglutition
0 1 2 3 4 0 1 2 3 4
0.2331% 41% 24% 4% 0% 39% 54% 7% 0% 0%
(9) (12) (7) (1) (0) (11) (15) (2) (0) (0)
Postswallow vallecular
pooling
0 1 2 0 1 2
0.1648% 42% 10% 45% 55% 0%
(14) (12) (3) (13) (16) (0)
Postswallow pyriform
sinus pooling
0 1 2 0 1 2
0.0683% 17% 0% 59% 41% 0%
(25) (5) (0) (17) (12) (0)
It is more difficult for patients with Parkinson’s disease to
initiate any movement from rest position rather than starting
the movement from a previous cueing event or prepara-
tory movement. Seeing this in the light of swallowing, initi-
ating the oral phase is more difficult without any cue or pre-
vious movement like the labiobuccal movements or sensorial
mucosal stimulation during drinking from a cup or chewing
of solid foods than delivery of the bolus by syringe. So, it was
decided to apply thin liquid boluses by syringe expecting the
highest chance of observing deglutition disorders because of
the motor challenge without any preparatory cue. However,
other consistencies, such as high-density barium boluses or
solid food consistencies, may lead to different dysphagic
observations [24]. The discrepancy between symptoms of
dysphagia in daily life and radiological results are common in
Parkinson’s disease, when comparing spontaneous behavior
with swallowing under highly controlled experimental con-
ditions [25]. Therefore, the question arises if the FOIS scale
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is a satisfactory measure for dysphagia severity in this patient
population, given the normal scores in the present study.
In order to design therapy effect studies for dysphagia in
Parkinson’s disease, it is necessary to understand the patho-
physiology of swallowing in this patient group. In previous
studies, several authors investigated pathological mecha-
nisms of oral-pharyngeal dysphagia in Parkinson patients
[9, 19]. Several authors suggested rigidity, hypokinesia,
and bradykinesia as factors underlying the disordered oral
and pharyngeal stages of swallowing [6, 9]. Also incom-
plete cricopharyngeal relaxation, reduced cricopharyngeal
opening, and delayed initiation of the swallowing reflex have
been suggested as possible mechanisms of dysphagia in this
population [9, 19]. The authors indicate that parkinsonian
patients may be “silent aspirators” with decreased cough
reflexes and lack of awareness of aspiration. Abnormal
findings in the oral and pharyngeal phase of swallowing were
described based on temporal and visuoperceptual variables.
Nagaya et al. observed that durational changes in the pha-
ryngeal phase of swallowing in Parkinson patients were
similar to natural changes in elderly control subjects [5].
In the present study differences in swallowing physiology
between Parkinson patients and age- and gender-matched
healthy control subjects were investigated using qualitative
and quantitative variables. These variables to evaluate the
oropharyngeal swallowing function in Parkinson’s disease
were obtained from the very few existing studies on this
matter [5, 6, 9, 19]. These studies showed group differences
between Parkinson patients and healthy control subjects.
However, methodological shortcomings were found in all
studies, for example, measurements in the “off” motor
phase of Parkinson’s disease, only one rater, no consensus
training in case of more raters, no blinding, no information
on the protocol of repeated measurements, neither on the
rating scale of the ordinal variables. So far, the evidence
of these studies is neither strong nor reliable enough to
serve as comparison for the present study. Despite diverse
methodological problems, these studies provided interesting
suggestions for variables that could be used in the present
study.
In this pilot study, few restrictions were placed on the
kind and number of parameters to use. Per swallow (N = 60
swallows in total) thirty variables were assessed, resulting
in 1800 measurements. The selection of parameters in
follow-up studies should be based on sufficient intra- and
interrater reliability as well as on a patient data distribution
using the full range of the parameters’ scale. The literature
on swallowing assessment usually provides only limited
information on the definitions of the parameters being used,
the exact description of the protocol applied during vide-
ofluoroscopy, the number of raters or the explanation of the
concept of an “expert” or “experienced” rater, the intra- and
interrater reliability, and the effect of training on reliability
coefficients. Interpretation of any study outcome lacking
such information may be hazardous. Dysphagic Parkinson
patients could potentially benefit from improved diagnostic
swallowing assessment by implementing well-defined vide-
ofluoroscopic parameters with sufficient intra- and interrater
reliability.
5. Conclusions
Despite the special attention paid to methodology in this
present study, insufficient reliability for fifteen out of thirty
variables (temporal, spatial, and visuoperceptual) was found,
particularly for the visuoperceptual variables. The reliable
variables could only reveal very few significant differences
between both pilot groups. Swallowing seems relatively pre-
served in the early stages of Parkinson’s disease. Recommen-
dations for future research on pathophysiological aspects of
swallowing in Parkinson’s disease may include study designs
with larger numbers of dysphagic patients and healthy
control subjects. It may be interesting too to include patients
with a more severe degree of Parkinson’s disease (higher
scores on the Hoehn and Yahr scale) to determine differences
between such a patient population and the patients who visit
speech therapists as described in this study. The present study
has found relatively low intrarater and interrater reliability
for many of the variables used despite thorough training and
high level of the raters’ expertise. In the literature, informa-
tion on reliability is usually lacking. After training, raters
should have maximum consensus about the exact definition
of the variables included and be familiar with the rating scales
being used as well as with their levels, preferably anchored in
detailed descriptions. Any swallowing study should provide
information on training and the intrarater and the interrater
reliability in order to allow accurate interpretation of the
study outcome. Maybe the suggestion that data described in
earlier studies may lack sufficient reliability and, therefore,
may not be useful in determining therapy outcome, has
been rather unexpected. Still, the problems with reliability
in outcome studies such as described in this paper may
also be the most interesting as well as the most important
finding. Newly developed research will need to take this
issue into account so that in the near future, in research
on the physiology of swallowing in Parkinson’s disease, the
complementary benefits of using qualitative as well as quan-
titative variables in videofluoroscopy can be studied more
thoroughly.
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